this'll give us a lil boost today .....
Tuesday March 23, 8:31 am Eastern Time
Company Press Release
SOURCE: ProCyte Corporation
Sigmacon in Distribution Agreement With ProCyte
3-Year Agreement Covers Skin Health and Hair Care Products
REDMOND, Wash., March 23 /PRNewswire/ -- ProCyte Corporation (Nasdaq: PRCY - news) today announced the signing
of a distribution agreement with Sigmacon Medical Products of Toronto, Canada for that company to market skin and hair care
products in the Canadian dermatology and cosmetic surgery markets.
Sigmacon is the largest supplier of cosmetic lasers and other equipment to physicians in Canada. Products sold by Sigmacon
are in most cosmetic and dermatology offices in Canada. The 3-year agreement contains minimum purchases and covers
ProCyte's GraftCyte(TM) products, Complex Cu3(TM) skin repair, Tricomin® products for thinning hair as well as the regular
physician label products.
''Linking with a major supplier of lasers to dermatologists and cosmetic surgeons provides immediate access to the full range of
ProCyte skin care and hair care products,'' said Jack Clifford, President and CEO, ''With our U.S. sales running significantly
ahead of last year, demand has also been increasing for our products in Canada.''
ProCyte recently announced agreements with Neutrogena for evaluation of the triamino copper complex technology in the mass
consumer market for hair products. ProCyte's non-drug solution for thinning hair in men and women, Tricomin®, is sold
primarily to physicians.
ProCyte Corporation is a healthcare company that develops, manufactures and markets products for tissue repair, skin health
and hair care. The Company's products incorporate its patented copper peptide technology and are marketed both directly and
through distribution partners.
This report may contain forward-looking statements. The Company's results may vary significantly from quarter to quarter and
will depend among other factors on product launches and market acceptance, manufacturing contracts, and distribution
agreements.
SOURCE: ProCyte Corporation
|
